Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of ...

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL ...

The neurodegenerative disease damages patients' motor, cognitive and behavioral controls, which sometimes manifest as ...

New data from a gene therapy trial provide the first credible evidence that the progression of Huntington’s disease may be ...

One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

The treated patients were compared against a cohort of people with Huntington's who received only standard care and are being followed in a long-term study called Enroll-HD. The trial runners used a ...

For the first time, scientists have successfully treated someone suffering from Huntington's disease, a fatal genetic illness with no cure.

FRIDAY, Sept. 26, 2025 (HealthDay News) — A new gene therapy has shown promise in slowing the progression of Huntington’s disease, according to early trial results released Wednesday.

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported ...

A company called uniQure has announced promising results from a trial of a new gene therapy for Huntington's disease. The ...

The director of UVA’s treatment program sees reason for “cautious optimism” after a small study’s positive results.